PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26403928-1	2015	Several series of novel non-thiourea-containing aminopyrazine derivatives were designed based on the MK-2 inhibitors 1-(2-aminopyrazin-3-yl)methyl-2-thioureas.	1-(2-aminopyrazin-3-yl)methyl-2-thioureas	117-158	MAPK activated protein kinase 2	Homo sapiens	101-105	
19423344-0	2009	Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).	1-(2-aminopyrazin-3-yl)methyl-2-thioureas	6-47	MAPK activated protein kinase 2	Homo sapiens	72-131	
19423344-0	2009	Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).	1-(2-aminopyrazin-3-yl)methyl-2-thioureas	6-47	MAPK activated protein kinase 2	Homo sapiens	133-137	
19423344-1	2009	Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas are described as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).	1-(2-aminopyrazin-3-yl)methyl-2-thioureas	6-47	MAPK activated protein kinase 2	Homo sapiens	79-138	
19423344-1	2009	Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas are described as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).	1-(2-aminopyrazin-3-yl)methyl-2-thioureas	6-47	MAPK activated protein kinase 2	Homo sapiens	140-144